Clinical Trial Update: Temozolomide in Treating Patients With Metastatic Non-small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update on temozolomide for metastatic non-small cell lung cancer. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Temodar (Temozolomide)

Snippet

Sponsor: Case Comprehensive Cancer Center | Conditions: Lung Cancer | Phase 2 | Status: COMPLETED